Is there a way to prevent long COVID? A new study in the United States found that taking metformin, an affordable first-line Type 2 diabetes drug, shortly after diagnosis of COVID-19 can reduce the risk of developing long COVID by about 41 percent. The study was conducted by researchers from the University of Minnesota, and…

The first cellular therapy for type 1 diabetes, called Lantidra, was approved by the Food and Drug Administration (FDA) for use in the United States. This is potentially good news for the 1.9 million people in the United States living with type 1 diabetes. The FDA approved the drug on June 28, after two clinical…

British Columbia is bringing in a new regulation immediately to ensure diabetes patients don’t face a shortage of the drug Ozempic, touted by celebrities for its weight loss side effects. Health Minister Adrian Dix says the change will ensure patients in B.C. and Canada needing Ozempic to treat their Type 2 diabetes will continue to…

Recently, the Food and Drug Administration of the Ministry of Health and Welfare of Taiwan (FDA) released a report about a new class of hypoglycemic drugs, Glucagon-like peptide-1 (GLP-1) receptor agonists, suspected of causing acute pancreatitis. Wang Chih-yuan, researcher and chairman of the Taiwanese Association of Diabetes Educators, said that patients who use GLP-1 receptor…

The U.S. House of Representatives passed legislation on March 31 that will limit the monthly cost of insulin to $35, a move that is claimed to be for the benefit of millions of Americans who depend on the drug. HR 6833 or the Affordable Insulin Now Act was sponsored by Rep. Angie Craig (D-Minn.). It…